Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

The9 Limited (NCTY) is undergoing a highly speculative pivot away from its legacy cryptocurrency mining operations back toward online gaming (via its Web3.5 GameFi platform 'the9bit') and AI-driven initiatives. While the company has reported rapid user growth on its new platform, its financial profile remains severely distressed. For the fiscal year ended December 31, 2025, the company reported a massive net loss of RMB402.4 million ($57.5 million USD) on revenues of just RMB107.9 million ($15.4 million USD), resulting in a deeply negative operating margin of -260.5%. Furthermore, the company faces persistent regulatory and compliance risks, including past notifications from Nasdaq regarding its failure to maintain the minimum stockholders' equity requirement of $2.5 million. Given the high execution risk of its new business model, severe cash burn, and potential dilution from its active $188 million shelf registration, we recommend a Sell rating.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$1.5030%

The bear case is triggered by a failure to maintain Nasdaq listing compliance, leading to delisting to the over-the-counter (OTC) market. This would be compounded by the failure or termination of the Nanyang Biologics SPAC merger and a rapid decline in user engagement on the9bit platform. Continued cash burn would force highly dilutive share issuances, driving the stock price toward historical lows.

Base CaseCentral scenario
$4.1350%

In the base case, The9's gaming joint ventures and the9bit platform generate modest revenues, but high operating expenses and product development costs continue to outpace income. The company remains unprofitable and relies on dilutive equity financing under its Form F-3 shelf registration to fund operations and maintain Nasdaq listing compliance. The stock is expected to trade in a volatile, downward-sloping range reflecting its weak fundamentals.

Bull CaseUpside scenario
$8.5020%

The bull case relies on the successful monetization of the9bit platform and its $9BIT token ecosystem, alongside a successful public listing of its investee Nanyang Biologics (NYB) via a $1.5 billion SPAC merger. If the9bit successfully converts its 8 million registered users into paying players and the $9BIT token appreciates significantly, the company's digital asset portfolio could drive a major re-rating. Additionally, a successful SPAC merger for NYB would provide a liquid, high-value asset on The9's balance sheet.

Scenarios reflect our research view at the research date.

Key Investment Merits
  • Rapid initial user acquisition on the9bit platform, surpassing 8 million registered users since its August 2025 launch.
  • Substantial digital asset holdings, including 950,000,000 9BIT tokens valued at approximately $19 million USD as of early 2026.
  • Potential upside from its equity stake in AI-driven drug discovery pioneer Nanyang Biologics (NYB), which has a pending $1.5 billion SPAC merger.
Sign in / Sign up to read more
Key Investment Risks
  • Severe financial distress, characterized by a net loss of RMB402.4 million ($57.5 million USD) and negative operating cash flows of -$4.5 million USD in FY2025.
  • Nasdaq delisting risk due to historical non-compliance with the minimum stockholders' equity requirement of $2,500,000.
  • High execution and regulatory risks associated with the pivot to Web3.5 GameFi and cryptocurrency-related business models in volatile regulatory environments.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Official delisting of NCTY American Depositary Shares from the Nasdaq Capital Market.
  2. Termination of the business combination agreement between Nanyang Biologics and RF Acquisition Corp II.
  3. A regulatory crackdown on the $9BIT token ecosystem or Web3.5 gaming rewards in key operating jurisdictions.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.